Genetic landscape of pediatric ependymoma
We performed whole-genome sequencing of 42 paired tumor/normal EPD genomes and analyzed somatically acquired single nucleotide variations (SNVs), insertion/deletions, structural variations and copy number variations in the cancer genomes
- Type: Whole Genome Sequencing
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples | 
|---|---|---|---|
| EGAD00001000162 | Illumina HiSeq 2000 | 44 | |
| EGAD00001000853 | Illumina HiSeq 2000 | 37 | |
| EGAD00001000854 | Illumina HiSeq 2000 | 77 | |
| EGAD00001001432 | Illumina HiSeq 2000 | 1337 | |
| EGAD00001001433 | Illumina HiSeq 2000 | 906 | 
| Publications | Citations | 
|---|---|
| Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data. Genome Biol 13: 2012 R113 | 22 | 
| C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506: 2014 451-455 | 360 | 
| CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data. Genome Biol 21: 2020 126 | 56 | 
| C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation. Acta Neuropathol Commun 9: 2021 36 | 14 | 
| The landscape of coding RNA editing events in pediatric cancer. BMC Cancer 21: 2021 1233 | 6 | 
| Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers. Nat Cancer 4: 2023 276-289 | 13 | 
